Telix Pharmaceuticals share price jumps 8% on ASX:TLX as JPMorgan crosses 5% — what to watch next
Sydney, Jan 28, 2026, 07:02 AEDT — Premarket Telix Pharmaceuticals Ltd shares grabbed attention ahead of the Australian open, closing Tuesday up 8.31% at A$11.86. The jump came after the company filed a fresh “substantial holder” notice with the exchange. (Intelligent Investor) Telix’s rebound catches attention, given it’s been one of healthcare’s worst performers in the last year, plunging roughly 57% over 12 months, according to market data. The company focuses on therapeutic and diagnostic radiopharmaceuticals — radioactive drugs for imaging and treatment — with Illuccix as its flagship imaging product. (MarketScreener) Telix is also a popular target for short